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Anxiety and depressive disorders are common mental disorders in general population, imposing 
tremendous burden on both affected persons and society. Moreover, comorbidity between anxiety and 
depressive conditions is high, leading to substantial disability and functional impairment. Findings 
consistently suggest that anxiety disorders are primary to depression in the majority of comorbid 
cases. Yet, the question of whether anxiety disorders are risk factors for depression, and potentially 
even causal risk factors for the first onset of depression, remains unresolved. Recent results have 
shown that anxiety disorders increase the risk for subsequent depression, and also affect the course of 
depression, resulting in a poorer prognosis. Further, some results suggest a dose–response-relationship 
in revealing that a higher number of anxiety disorders and more severe impairment associated with 
anxiety disorders additionally increase the risk for subsequent depression. The goal of this paper is to 
review recent literature, summarize implications of previous findings, and suggest directions for future 
research regarding preventive and intervention strategies.   
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1. Introduction  
 
Anxiety and depressive disorders have been found to be associated with extremely high health 
economic costs. Fairly comprehensive comparative analyses have revealed that among all 
mental disorders, anxiety disorders are associated with the highest total costs, followed by 
affective disorders (330.373 millions of US dollars) [37]. It is noteworthy that for affective 
disorders, the largest proportion of these costs are direct costs (e.g. related to treatment and 
intervention), whereas the bulk of costs of anxiety disorders occurs primarily in indirect costs 
(e.g. value of lost output resulting from reduced productivity, disability, etc.). This remarkable 
difference has been attributed to the higher prevalence, earlier age of onset, and more frequent 
chronic courses of anxiety disorders in combination with the lower proportion of patients with 
anxiety disorders receiving any treatment. The increasing evidence for such tremendous, yet 
differential, diagnosis-specific health economic impact and the fact that anxiety and 
depressive disorders frequently occur together [20,24,46] has made the search for more 
effective preventive and treatment strategies a high priority issue in research. In the core of 
such considerations is the question of the degree to which anxiety disorders precede 
depressive disorders and whether it is possible to reduce not only the incidence of anxiety 
disorders and to improve their natural course by means of earlier and more aggressive 
treatment, but also whether it is possible to reduce the incidence of secondary depression. 
This important second goal refers to the attractive speculation that anxiety disorders as 
predominantly early manifestations of mental disorders might constitute a causal risk factor 
for the subsequent development of depressive disorders and a more malignant further course 
in terms of more frequent depressive episodes, longer duration of episodes, and a higher 
frequency of chronic depression.  
 
A significant obstacle in this respect has been the lack of convincing data that support the 
assumption of the causal role of primary anxiety disorders as an important pathway toward 
the prevention of the onset of secondary depression. Further, there are few available data to 
date that provide clues for the core aetiopathogenic processes involved in this pattern.   
 
This paper reviews the available evidence for these claims primarily using data from 
epidemiological surveys, focusing in particular on prospective-longitudinal findings in 
community samples.  
 
2. The epidemiology of anxiety and depressive disorders  
 
2.1. Prevalence  
 
Data from representative community samples carried out across the world (USA, Canada, 
Switzerland, Netherlands, Norway, Germany, Italy, Great Britain, Australia) have revealed 
quite consistently that anxiety and depression are frequent mental disorders with lifetime-
prevalences for any anxiety disorder ranging from 15% to 25% and for any depressive 
disorder ranging from 10% to 18% [1,3,11,12,16,23,29,33,38,41,42,58].Among the anxiety 
disorders, specific phobias are diagnosed most frequently, followed by social phobia. The 
prevalence estimates for generalized anxiety disorder (GAD) and agoraphobia are somewhat 
lower, but substantial (4–6%). Obsessive–compulsive disorder and panic disorder are less 
frequent (1–3.5%). Fewer studies have reported prevalence rates for posttraumatic stress 
disorder (PTSD) and most of these findings have shown considerably wider variation with 
estimates ranging between 1.3% and 1.6% in Germany [11,33,58], and 8.4% in the US [41]. 
In comparison with these lifetime rates for anxiety disorders, 12-month estimates are 
generally lower, yet the pattern of relative prevalence rates of the specific anxiety disorders is 
consistent across studies. Among depressive disorders, major depressive episodes (MDE) are 
most frequent (9–17%), whereas the prevalence estimates of dysthymia range between 2% 
and 6% [3,23,33,41,42].  
 
2.2. Onset of anxiety and depressive disorders  
 
Also consistent across both cross-sectional retrospective and prospective incidence studies, 
anxiety disorders have consistently been found to have an early onset dated in childhood, 
adolescence or early adulthood [56]. Except for GAD, panic disorder, and agoraphobia, which 
may occur with differing incidence patterns, both in adolescence and more frequently in later 
life, the typical age at risk for developing a phobia is clearly childhood or early adolescence– 
onset after age of 20 years seems to be a rare phenomenon [30,44,49,56]. Among all anxiety 
disorders, the pattern of onset with GAD seems to be remarkably different from that seen with 
other anxiety disorders. In most studies, prevalence rates for GAD in adolescents and young 
adults are usually low and then increase substantially with age [51]. In fact, analysis of the 
National Comorbidity Survey (NCS, USA) and German National Health Interview and 
Examination Survey–Mental Health Supplement (GHS) seem to suggest that GAD appears to 
be an anxiety disorder with consistently later onset, relative to phobias for instance, and 
appears more similar to the onset characteristics seen in affective disorders [8,59]. Yet, it 
should be noted that this does not necessarily indicate that individuals with onset of GAD in 
adulthood have been healthy prior to meeting the full criteria. Wittchen et al. [54] 
demonstrated that the majority of all GAD cases had been suffering from at least one 
childhood or adolescent anxiety disorder of other type prior to GAD onset.  
 
In remarkable contrast to anxiety disorders, major depressive disorders have their first onset 
considerably later in late adolescence, early adulthood or even late life. Findings from the 
International Consortium of Psychiatric Epidemiology (ICPE) Surveys revealed that the 
median age of onset of MDE is in the early to mid-twenties and thus about 5–8 years later 
than the mean age for anxiety disorders. Unlike anxiety disorders (except for GAD), the risk 
of MDE continues throughout the life course [1]. According to data from the epidemiologic 
catchment area (ECA) study, the highest hazard rates occurred for both females and males at 
the ages 15–19 and 25–29 years [7]. Similar findings have also been reported from 
prospective-longitudinal studies in young adults [34].  
 
2.3. Patterns of course  
 
Both anxiety and depressive disorders also reveal remarkable differences with regard to 
course.  
 
The most frequent course of anxiety disorders can be described as chronic-mild and persistent 
[45]. This characterization, however, is frequently misunderstood as meaning that each type 
of anxiety disorder, if present, persists on the threshold level over years or even the life-
course. This is not the case; in fact, the typical picture is a waxing and waning pattern of 
symptomatology (symptomatic, subthreshold, threshold) with frequent syndromal shifts 
within the anxiety spectrum (shifts from specific to social phobia, from panic/agoraphobia to 
GAD or other phobias, etc.) [55]. The course of social anxiety disorder, for example, has been 
recently examined in a 3-wave follow-up study of 3021 adolescents and young adults [58]. 
The majority of cases of social anxiety disorder had their onset before the age of 18 years 
[47], and not infrequently even earlier in childhood. Until that time, the disorder was in the 
vast majority described as already progressive worsening or persistent: However, there was a 
considerable degree of waxing and waning in symptomatology, most likely due to challenges 
in life. Stable remission was found to be rare and limited to less than 20%. Similar findings 
are available from the ECA study covering almost the whole lifespan: rates of remission 
(defined as: free of symptoms during the past year) were 42% in panic disorder and 38% in 
phobias. The mean duration of panic disorder (in remitted cases) is 7.1 years. Phobias have a 
longer duration of 15.4 years and subjects with obsessive– compulsive disorder had this 
disorder for 6.4 years [10,38]. Regarding GAD, more than 40% of subjects had the disorder 
for more than 5 years and more than 10% for more than 20 years [5].  
 
This relatively high degree of symptom stability among anxiety disorders is in sharp contrast 
with that typically found for depressive disorders in the community.  
 
The predominant pattern among community cases with depression is rather episodic with an 
average length of 3 months per episode [39,57] and, at least in the first three decades of life, 
chronic depression constitutes only a small proportion of all persons affected. Overall, the 
best estimate seems to be that one-third remit completely with no further residual symptoms 
nor with recurrent episodes, one-third report recurrent episodes with full remission in 
between. For the remaining one-third or less, a chronic course with a fluctuating and 
unremitting course can be expected. Results from the ICPE Surveys revealed that nearly 75% 
of individuals who met diagnostic criteria for lifetime MDE reported recurrent episodes [1]. It 
is noteworthy though that these estimates depend heavily on type of age cohort considered as 
well as type of depressive disorder. Even in adolescence, unfavorable prognoses have been 
reported for early onset depression and dysthymia (43% of depression cases and 33% of 
dysthymia cases revealed complete remission). Adolescents and young adults with dysthymia 
have the least favorable outcome, 29% of those with a baseline dysthymia developed a major 
depression and 24% met full diagnostic criteria for dysthymia again at follow-up [34].  
 
3. Patterns of comorbidity: is anxiety primary?  
 
Comorbidity is a fundamental characteristic of all anxiety and depressive disorders, and is not 
confined to some disorders such as GAD, believed to have exceedingly high comorbidity 
rates. Using data from the cross-sectional NCS, Kessler analyzed subjects with anxiety and 
depressive disorders regarding 12-month and lifetime comorbidity [20].  
 
As can be seen in Table 1, only up to one-fifth of respondents with a 12-month anxiety 
disorder did not meet 12- month and lifetime criteria for any other mental disorder surveyed. 
Therefore, they can be regarded as having a pure anxiety disorder over their lifetime. About 
the same number of people had a pure anxiety disorder in the 12-month period, yet they had 
also experienced at least one comorbid disorder prior in their lifetime. The largest proportion 
of the persons with a 12-month anxiety diagnosis had another disorder in the same 12-month 
period and lifetime. A similar picture emerged for the affective disorders (Table 2). More than 
two thirds of subjects with any affective disorders met criteria for at least one other mental 
disorder in their lifetime and in the 12-month period prior to the investigation. This finding 
has been replicated in someway or the other by numerous studies [2,24,32,36] and has 
highlighted not only that anxiety and depressive disorders are closely associated, but also that 
pure anxiety disorders are quite rare both cross-sectionally and lifetime. Due to the 
retrospective nature of these data, however, it remained unresolved whether comorbid patterns 
differ by type of anxiety disorder and patterns of temporal sequence.  
 
Cross-sectional studies of this type are limited to the use of retrospectively reported age of 
onset to reveal that most anxiety disorders start early and that depressive disorders usually 
start later in life [32,36]. Recent analyses of the NCS data revealed that more than 80% of any 
anxiety disorders are the primary disorder, leaving less than 20% that occur secondary to 
another primary disorder [20]. Specific phobias are most frequently primary disorders (68%) 
followed by social phobia (63%), PTSD (52%), agoraphobia (45%), GAD (37%), and panic 
disorder (23%). In contrast, depressive disorders less frequently occur as primary disorders. In 
addition, other studies have consistently shown that major depression emerges after the onset 
of the anxiety disorder in the majority of cases and, therefore, can be regarded as secondary 
[12,32,36].  
 
Yet, cross-sectional studies rely on retrospective information of the ages of onset in order to 
determine the sequence of disorders and, therefore, are handicapped by possible recall biases. 
Prospective-longitudinal studies are more adequate to ensure the temporal-relationship 
between anxiety disorders and depression. One of these rare studies is the early 
developmental stages of psychopathology (EDSP) study carried out in Munich, Germany. 
This study included one baseline and two follow-up assessments over a period of 5 years.  
 
Fig. 1 gives the proportions of pure anxiety cases and those comorbid with depression for the 
cohort of 14–17 years old at the baseline investigation. Consistent with relatively low 
prevalence rates for depression, less than 20% of cases with an anxiety disorder had ever 
experienced a comorbid major depression or other threshold depressive disorder. 
Approximately, 2 years later at the first follow-up, these comorbidity rates almost doubled 
(not shown), and approximately 5 years later (Fig. 2), at the final follow-up of the EDSP, 
there is a dramatic increase in subjects with an anxiety disorder also meeting criteria for major 
depression or other threshold depressive disorders. In the majority of cases with either form of 
specific anxiety disorders, the proportion of comorbid depression in anxiety is clearly over 
50%. The highest comorbidity rates with depression can be seen for GAD, separation anxiety 
disorder (SAD) and panic disorder, yet even the comorbidity rates for specific phobias of any 
type are only marginally lower. Similar results were recently reported for the entire sample of 
the EDSP study (14–24 years at baseline; [53]).  
 
Clearly these prospective-longitudinal data in a representative community sample provide 
much stronger evidence for the predominant pattern of temporal precedence of anxiety 
disorders over depressive disorders. Despite the fact that this finding fulfills one core 
requirement in the process of establishing the status of anxiety disorders as a causal risk factor 
[26], the question of whether this can be interpreted as anxiety disorders being (causal) risk 
factors for secondary depression remains.  
 
4. Is anxiety a causal factor and a target for early intervention/prevention of depression?  
 
What are the potential etiological, pathogenetic, and clinical consequences of the high 
comorbidity between anxiety disorders and depression? Why do anxious subjects become 
depressed? Are anxiety disorders risk factors for subsequent depression?  
 
Research regarding risk factors has been hampered by the use of inconsistent terminology 
such as risk, risk factor and cause, leading to the application of inadequate methods and 
deceptive interpretations. Kraemer et al. [26] made an attempt to clarify these terms in 
developing a typology. Within this typology, a correlate is associated with the outcome but 
does not necessarily precede the outcome. Only if precedence can be proved, the term risk 
factor may be used.A risk factor, which can be shown to change spontaneously within a 
subject (e.g. age or weight) or by intervention (e.g. drugs or psychotherapy), can be called 
variable risk factor. If a change is not possible (e.g. gender, birth cohort, or race), the term 
fixed marker is proposed to be used. The term causal risk factor is only appropriate, if a 
variable risk factor can be shown to be manipulable and to change the risk of the outcome. If 
this is not the case (e.g. genes), the term variable marker should be used. Kraemer et al. also 
stress that prospective-longitudinal studies are necessary to identify risk factors in order to 
insure the temporal precedence of the factor and the outcome.  
 
Applying this model to the prospective-longitudinal EDSP data reveals that when using 
cumulative data over 5 years (Fig. 3), the likelihood of developing a major depression if one 
has a primary anxiety disorder increases significantly. In the total sample of subjects aged 14–
24 years at baseline, and up to the age of 29 years, subjects with no anxiety disorder have a 
relatively low chance of developing a major depression. However, if one has a primary 
anxiety disorder, or especially a GAD, the risk for secondary depression increases 
dramatically.  
 
Also, strictly prospective analyses reveal that any pure and primary anxiety disorder as well as 
the specific anxiety disorders (social phobia, specific phobia, agoraphobia and GAD) at 
baseline significantly increase the risk of first onset of depression during the 5 year follow-up 
period [4]. Although GAD appeared to have the strongest association with subsequent 
depression (Odds ratio (OR) = 4.5; 95%- KI = 1.9–10.3), the ORs for the other anxiety 
disorders are also quite high and consistent. This finding holds true even when adjusting for 
age, gender, and comorbidity.  
 
These results are consistent with previous findings from prospective data of the ECA study 
[15] in adults and older people. The occurrence of specific phobia, agoraphobia, obsessive– 
compulsive disorder, and panic attacks significantly increased the risk for first onset of major 
depression, even after adjusting for sociodemographic differences and other psychiatric 
comorbidity. Goodwin suggested that each anxiety disorder and panic attacks appear to make 
an independent contribution to the risk of depression.  
 
Our data go beyond these earlier findings, because they were collected prospectively in 
adolescents and young adults—the key risk period for first onset of anxiety disorders and 
secondary depression.  
 
However, the pathways leading from anxiety to depression are still not identified. At least two 
different perspectives have been suggested (see [53]). Frst, anxiety and depression may share 
identical or at least similar vulnerability and risk factors. According to the “lumpers”-
perspective, anxiety is merely regarded as a prodromal stage or alternatively as a severity 
marker of depression. Lumpers usually come to their conclusion using dimensional and cross-
sectional data [27,28,50]. In contrast, the “splitters”-perspective assumes that anxiety and 
depressive disorders are separate disorders with sufficiently specific and different 
vulnerability and risk factors. Within this perspective, anxiety disorders are not only 
important risk factors for the development of depressive disorders, but also this distinction 
bears important and promising preventive and therapeutic consequences that are believed to 
be different for each of the anxiety disorders on one hand, and for depression, on the other. As 
mediating variables for this risk constellation, the splitters assume processes like 
demoralization, the accumulation of depression-specific risk factors (e.g. avoidance behavior), 
or an increasing sensitization of cognitive-behavioral and neurobiologic processes.  
 
It is noteworthy that among the anxiety disorders, there is a still considerable controversy 
regarding the nosological status of GAD and whether GAD should be considered in the same 
way as other anxiety disorders. The repeated observation that GAD is highly associated with 
depression has led to the conclusion that both disorders are part of the same spectrum, and 
that GAD is merely a prodrome, residual, or severity marker of depressive disorders (e.g. 
[6,31]). Some support for this model comes from the similarity of age of onset patterns of 
GAD and depression, and factor analyses have revealed that GAD appears to be more closely 
related to depression, than to the other anxiety disorders [27,28,43]. Moreover, twin studies in 
females have shown that contrary to other anxiety disorders, GAD and depression appear to 
share a similar set of non-environmental factors, and thus might have a similar genetic 
disposition [17–19]. However, there is more evidence from recent studies that GAD should be 
conceptualized as an independent disorder, based on the following observations: GAD and 
major depressive disorder have different prevalence rates, different patterns of diagnostic 
overlap, different risk factors, and associated features. Also, substantial impairment has been 
found for pure GAD not comorbid with depression [8,21,22,52,59].  
 
Recent analyses (a) deal with the underlying mechanisms under which secondary depressions 
are most likely to develop and (b) examine whether the severity and type of symptoms of 
secondary depression are different from those of other forms of MDE. Wittchen et al. [53] 
have analyzed data from a prospective-longitudinal community study and found that the 
following characteristics of anxiety disorders (at baseline) were significantly associated with 
an increased risk of secondary depression: the number of anxiety disorders, the impairment, 
the frequency of avoidance behavior and the presence of panic attacks. Recent findings 
further suggest that among various clinical characteristics of anxiety disorders (number of 
comorbid anxiety disorders, impairment, presence of panic attacks) severe impairment 
emerges as the strongest predictor of major depression [4]. Further analyses from the same 
study have revealed that individuals who have both depressive disorders and social phobia 
experience a more malignant course of depression compared to respondents with depression 
or social phobia alone [40]. During the follow-up period, these persons were significantly 
more likely to experience more intensive suicidal ideation, more depressive symptoms, and a 
longer duration of MDE. They also had a significantly greater risk of having attempted 
suicide (see Table 3).  
 
To sum, beyond the finding that anxiety disorders usually precede depression, increasing the 
risk for incident depression about threefold, even after 4–5 years, the increasingly sharper 
picture of the various mediating factors and processes make it appear extremely likely that 
anxiety disorders can be powerful causal risk factors for secondary depression.  
 
5. Clinical and psychosocial consequences of anxiety–depression comorbidity  
 
Anxiety disorders and depression are associated with a wide range of psychosocial 
impairments and disabilities that may differentially affect development processes, such as 
career, work productivity, partner and interactional integration, and quality of life as well 
critical health outcome, such as suicidal behavior and treatment. Further, it should be noted 
that the profile of disabilities may, but must not inevitably, be more pronounced among those 
affected by both conditions. For instance, in the German health study (GHS) 10.9% of those 
with pure GAD and 7.9% of those with pure major depression reported a reduction of at least 
50% in their activities in the past month [48].Among those with comorbid GAD and major 
depression, this proportion is substantially higher (23.2%). Moreover, 34.3% of pure GAD 
cases and 20.8% of the pure subjects with major depression had at least 6 days that were 
impaired in the past month. But again, respondents with comorbid GAD and major depression 
were more frequently impaired (47.6%). Wunderlich et al. [60] investigated the risk for 
suicide attempts among anxiety and depressive disorders as well as among subjects with 
comorbid presentations (EDSP). Seventy-nine percent of all suicide attempters had at least 
two mental disorders. The risk for suicide attempts was significantly increased in subjects 
with two diagnoses (OR = 3.5; 95%-CI: 1.3–9.1), three diagnoses (OR = 6.4; 95%-CI: 2.4–
16.9) and more than three diagnoses (OR = 18.4; 95%-CI: 7.8–43.6). Regarding separate 
diagnoses, all anxiety (GAD, social phobia, panic attack, agoraphobia, simple phobia, 
obsessive–compulsive disorder, PTSD) and depressive disorders (MDE, dysthymia) were 
significantly associated with suicide attempts (OR = 2.2 and higher). Using multivariate 
analysis of various comorbidity patterns, the authors also found that all significant findings 
involved comorbidity between anxiety and depressive disorders.  
 
Additionally, anxiety disorders influence the form, severity, and duration of secondary 
depression (see above; [40]).  
 
6. Summary and conclusion  
 
At least when relying on the integrity of epidemiological data and prospective-longitudinal 
data from studies in the first three decades of life, there is increasing evidence that anxiety 
disorders are usually primary to the onset of depression, and increase differentially by type, 
and number of anxiety disorders, the risk for subsequent depression. Anxiety disorders also 
affect the course of depression in increasing the risk for an earlier onset of depression, which 
is believed to be more frequently associated with a particularly malignant course, which 
includes the risk for more intensive suicidal ideation and attempts, and longer duration of 
depressive episodes. In addition, the number of depressive symptoms are increased in subjects 
with primary anxiety disorders. Further, it can be assumed that the effect size follows dose–
response relationships in showing that a higher number of anxiety disorders, and the 
associated higher level of severe impairment, additionally elevate the risk for secondary 
depression. Finally, little doubt remains regarding the question of whether primary anxiety 
disorders associated with secondary depression increase the risk for a wide range of more 
severe psychosocial impairments and disabilities.  
 
Given this strong link, it is curious that similar data have only rarely been reported in previous 
clinical samples. At least four factors seem to contribute to this past omission: first, 
epidemiological findings, especially in primary care [52], have fairly consistently shown that 
anxiety disorders are frequently regarded as non-severe disorders, thus they remain much 
more frequently undiagnosed and untreated in the health care system, as does depression, for 
example. Anxiety disorders are primarily recognized and treated if they present with 
comorbid depression. Second, clinical samples in treatment are usually much older than cases 
identified and studied in epidemiological research, and further most usually present with both 
conditions, and as such, making a diagnostic separation of the two groups is a clinical 
challenge, especially due to reliance on retrospective assessments. Third, most clinicians are 
still not following strictly the DSM-IV and ICD-10 differential diagnostic classification, 
preferring instead a syndromatic approach that lumps together anxiety and depression. And 
fourth, clinical randomized studies usually employ a long list of exclusion criteria, thus, a 
considerable proportion of the most frequent comorbidity patterns are systematically excluded 
in clinical trials.  
 
6.1. Implications for further research  
 
The strong evidence for the case of primary anxiety disorders serving as causal risk 
constellations has a number of exciting perspectives for both effective prevention and 
improving early treatment approaches. Based on available evidence, it appears time for major 
prevention trials. For example, (a) can we change the risk for secondary depression by earlier 
recognition and treatment of anxiety disorders in the first two or three decades of life? (b) 
How many incident cases of depression can we avoid by such strategy? (c) Can we change the 
length of depressive episodes and the risk for recurrence more effectively by targeted 
intervention on primary and presumably persistent anxiety disorders?  
 
Yet, there remains an unfortunate number of open questions that currently hamper our ability 
to design such interventions appropriately. Examples include the following:  
 
(1) To date, anxiety disorders could be shown to be variable risk factors according to the strict 
typology of Kraemer et al. [26]. Admittedly, it remains an unresolved issue whether and why 
anxiety disorders are causal risk factors for first onset of major depression. Although recent 
findings from prospective epidemiological studies suggest a causal role of anxiety disorders in 
the etiology of depressive disorders, the mediating processes remain largely unknown. Future 
targeted clinical and epidemiological studies are needed to clearly answer these questions.  
 
(2) Are all anxiety disorders the same? Findings suggest that there are differences in the 
temporal-relationships between the specific anxiety disorders and depression. For example, 
specific phobia is consistently shown to have its onset primary to depression in about 80% of 
cases whereas GAD only occurs prior to depression in about 35% of cases. Despite this 
finding, all anxiety disorders increase the risk of subsequent depression significantly whereas 
GAD seems to have the strongest association.  
 
(3) To what degree do specific anxiety disorders and depression have different or shared 
vulnerability and risk factors? Some findings favor the perspective that there is at least 
significant evidence for the separation of various anxiety disorders from major depression in 
terms of risk factors and natural course. Nevertheless, this problem remains unresolved, since 
there are also contrary findings (e.g. findings from twin studies).  
 
6.2. Public health implications  
 
As findings consistently show, the prevalence of depressive disorders is high, even in young 
people [29,58], and there are enormous associated economic health costs and impairments 
[37]. Thus, effective strategies for prevention are increasingly important. Prevention trials are 
rare, and mainly characterized by unspecific intervention modules that do not target specific 
vulnerability and risk factors of depressive disorders. Most studies have found only moderate 
effect sizes [9,13,35]. Nevertheless, keeping in mind that primary anxiety disorders are risk 
factors for secondary depression, and that the presence of anxiety disorders has considerably 
adverse effects on the course of depression, some implications for prevention and clinical 
management can be outlined. In particular, early intervention programs may be promising. 
Specifically, it should be investigated whether the treatment of early primary anxiety 
disorders can prevent onset of secondary depression and other complications and 
impairments. Approximately, 10% of mood disorders may be prevented by successful early 
intervention with social phobia [25]. Explorative analyses of the EDSP data have revealed 
that if all anxiety disorders among 14–24 years old would be successfully treated one would 
be able to prevent 43% of all depressive episodes in early adulthood (attributable population 
risk fraction, lower limit). Preliminary results are promising in showing that treatment of 
panic attacks may reduce the risk of developing major depression [14]. Randomized clinical 
studies with a longitudinal design over at least 3 years are needed next to explore whether 
treatment of anxiety disorders decreases the risk of subsequent major depression. Within 
routine clinical care, it is necessary to always examine prior histories of anxiety disorders in 
depression and to consider unfavorable effects of undetected anxiety for the course of 
depression. Therefore, a more comprehensive life-cycle assessment of mental disorders 
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